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A 49-year-old man presented with slurred speech, memory loss, and behavioral changes. His 
clinical course was marked by decline in functional status and cognition. He had poorly controlled 
hypertension and hyperlipidemia. Neuroimaging was remarkable for multiple subcortical white 
matter lesions. We discuss the diagnostic and therapeutic approach of rapidly progressing 
cognitive decline in the given clinical setting.
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However, this was followed by episodes of gait difficulties and 
increased drowsiness, followed by an overall decline in his ability 
to perform tasks of daily living. He continued to have a fluctuat-
ing course and his cognition suffered a significant decline. He 
was witnessed to have a seizure and was subsequently started 
on levetiracetam.
Medications include aspirin 81 mg daily, lisinopril–HCTZ 
10–12.5 mg daily, nifedipine 90 mg twice daily, folic acid, Coenzyme 
Q10, Fish oil, Vitamin B complex, atorvastatin 20 mg.
Past medical history was noteworthy for meningitis at the age 
of 19, mononucleosis at the age of 29, and recently diagnosed arte-
rial hypertension. He worked as a manager in an Information and 
Technology firm. He smoked a pack of cigarettes a day for the past 
20 years. He was divorced. He was not sexually active. He had family 
history of arterial hypertension.
Neurological examination was remarkable for a flat affect. He 
was disoriented to time and had deficits in attention and concen-
tration. Four word span was 4/4 at 1 min without distraction, 3/4 
at 1 min with distraction, and 2/4 at 6 and 45 min respectively. 
He could recite the months of the year forward in 9 s (paused 
between September and October) but took >40 s backward and 
got stuck at June. Digit span test was 7 forward, and 3 backward. 
He could draw the face of a clock with correctly placed numbers 
but could not place the hands of a clock at the right place. He was 
able to read and write numbers correctly. He could add single and 
multi- digits correctly but made mistakes in  single and multi-digit 
multiplication. Benton face recognition screening was normal. 
He had no neglect on letter cancelation test.
His speech was dysarthric with mild word finding pauses. Naming, 
repetition, comprehension and reading were intact. Writing was 
“messy” but he was able to spell correctly and the syntax was intact. 
Cranial nerve examination was normal except for funduscopic 
examination that showed focal areas of infarct lateral to the left disc 
History: A 49-year-old left handed man presented to us with 
concerns of memory loss, slurred speech and behavioral changes. 
His symptoms started a year earlier while on vacation (biking) in 
Tuscany, Italy with his sister. His sister recalled he appeared more 
quiet than usual. During the ensuing days, other family members 
also noticed he was unusually quiet and his speech was slurred; this 
was attributed to fatigue from travel and wine. After he returned 
from vacation to his work in the Midwest, his co-workers noted 
similar changes. Subsequently, the patient began to suspect prob-
lems himself, when he missed a few days of work, 3 months after 
his symptoms were recognized while in Italy. Over the ensuing 
2 months, he had increasing difficulties arriving to work on time, 
became more disorganized at home and at work, and had more 
difficulties remembering things. Six months after onset of symp-
toms, he was asked to see a physician by his supervisor at work. 
At the physician’s office, the nurse thought his speech was slurred 
and recorded a blood pressure of 240/160 mm Hg. He was then 
admitted to a local hospital where he was noted to have short term 
memory impairment, slurred speech, word finding difficulties and 
behavioral changes including wandering, impulsivity and inappro-
priate sexual overtures to hospital staff. He was then transferred 
to a tertiary care hospital for further management. A detailed 
workup was done at the hospital, which is discussed further below. 
Subsequently, he had rehabilitation therapy and slow improve-
ments were noted on his memory and organizational skills. At this 
time, he was able to prepare simple meals using the microwave but 
not the stove. He would accompany family members on errands, 
medical appointments, taking walks and reading. Moreover, he 
was independent for personal activities of daily living.
He was subsequently transferred to a rehabilitation center where 
he continued to show improvement in memory. Some improve-
ment was also noticed in performing activities involving organi-
zational and executive skills.
Edited by:
Osvaldo Fustinoni, Universidad de 
Buenos Aires, Argentina
Reviewed by:
Osvaldo Fustinoni, Universidad de 
Buenos Aires, Argentina
Maria Zurru, Hospital Italiano, 
Argentina
*Correspondence:
José Biller, Department of Neurology, 
Stritch School of Medicine, Loyola 
University Chicago, 2160 South 1st 
Avenue, Building 105, Room 2700, 
Maywood, IL 60153, USA.
 e-mail: jbiller@lumc.edu
www.frontiersin.org April 2011 | Volume 2 | Article 27 | 1
cpc Article
published: 28 April 2011
doi: 10.3389/fneur.2011.00027
microbleeds (Figure 3). MRA (not shown) of the extracranial 
and intracranial circulation showed a 1.2 mm × 2 mm right 
A1–A2 junction aneurysm, and a 1.1 cm × 0.4 cm irregular out-
pouching from the right vertebral (V2)segment consistent with 
a pseudoaneurysm likely related to a chronic dissection. There 
was no evidence of flow-limiting stenosis within intracranial 
or extracranial vessels. Catheter cerebral angiogram showed a 
single M3 branch vessel of the right MCA with mild irregularity 
on magnification lateral views, a 3-mm anterior communicating 
artery (ACom) aneurysm, and a right V2 segment mild verte-
bral artery pseudoaneurysm consistent with remote dissection. 
There was also mild to moderate intracranial dolichoectasia, 
particularly of the basilar artery.
EEG revealed mild background slowing but no epileptiform 
activity was noticed. Chest X-ray was normal. CT chest abdomen 
pelvis were unremarkable. MRI of the cervical and thoracic spine 
were normal. Cerebrospinal fluid (CSF) testing showed, clear and 
colorless CSF with glucose of 59 (normal when compared to blood 
glucose), WBC:1, RBC:0. Cytology was negative for malignancy. 
Viral (HSV, VZV, CMV, JC virus), bacterial, and fungal cultures 
were all negative. Hypercoagulable profile, Apo E genotyping, 
CADASIL gene testing, autoantibody screen (C-ANCA, P-ANCA, 
SS-A, SS-B, complement levels, Scl-70, Anti Jo, RNP, ANA, Anti 
Smith Ab, cryoglobulins), and catecholamine levels. All of the above 
tests were normal.
The patient underwent a brain biopsy (Figures 4–7).
What is your diagnosis?
Figures 4 and 5 shows thickened hyalinized barrel-shaped arteri-
oles. Figure 6 shows a focal area of lack of myelination. The myelin 
loss was variable with white matter reactive astrocytosis (GFAP 
stain; Figure 7) and microgliosis (CD68 stain; not shown). In gen-
eral, the blood vessels showed narrowing and hyalinization without 
occlusion. These features were consistent with subcortical arterio-
sclerotic leukoencephalopathy (Binswanger’s disease).
and medial to the right disc. He had mildly spasticity in both upper 
extremities, and moderate spasticity in the lower extremities. He 
had 5/5 strength in both upper extremities. Hip flexion, knee exten-
sion, knee flexion, foot plantar flexion, foot dorsiflexion were 4/5 
bilaterally. He had no tremors. He had a right “cortical fist” attitude, 
and bilateral palmar grasp responses. A snout reflex was present. 
Vibration and temperature sensation was intact except for slight 
reduction on the left foot. Position sense was intact. Sensation to 
light-touch was intact. There was no extinction to double simultane-
ous stimulation. Graphesthesia and stereognosis were unremarkable. 
He had slow and clumsy bilateral rapid alternating movements. Mild 
dysmetria was observed on finger to nose test bilaterally and on heel 
knee shin test on the left. Muscle stretch reflexes were hyperactive 
throughout. There was a Hoffman’s sign on the right. The left plantar 
response was flexor. He had a right Babinski sign. There was mild 
ideomotor and limb-kinetic apraxia. Oral praxis was intact. He had 
a mildly unsteady gait. He had normal arm swing and turns, but was 
mildly unsteady with tandem gait. Romberg was negative.
Ancillary studies showed a normal complete blood count, nor-
mal basic metabolic profile, a serum cholesterol of 137 mg d/l, 
Triglycerides 91/mg/dl, HDL of 39 mg/dl, LDL of 80 mg/dl. HbA1c 
was 5.4. Urine drug screen was negative. Plasma  homocysteine 
was elevated at 24.2 μmol/l. Urine analysis and erythrocyte sedi-
mentation rate were normal. RPR was non-reactive. Serum B12 
and Folate levels, and TSH were all normal.
Transesophageal echocardiogram showed normal left and right 
ventricular size. The left ventricular ejection fraction was 60%. There 
was no left atrial thrombus. The left atrial appendage was free of 
thrombus. There was no evidence of interatrial communication or 
R–L shunt by bubble contrast study. The heart valves were normal.
MRI of the brain showed bilateral periventricular white mat-
ter and subcortical white matter ischemic changes (Figures 1 
and 2). Gradient Echo imaging showed multiple subcortical 
Figure 1 | T2 FLAir. Figure 2 | T1 FLAir.
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ConCise disCussion
Binswanger’s disease, also known as Subcortical Arteriosclerotic 
Encephalopathy was initially recognized by Otto Binswanger in 1894, 
and Alois Alzheimer first coined the term “Binswanger’s disease” in 
1902 (1994; Pantoni et al., 1996). Binswanger recognized a total of 
eight cases in his original study, but defined the gross pathology in only 
one of them. Later on Alzheimer described the pathology and clinical 
characteristics of the disease and proposed it as a separate entity. An 
earlier review by Babikian and Ropper (1987) reported only 47 cases 
before 1987. Since then, additional cases of Binswanger’s disease have 
been reported primarily due to the use of modern neuroimaging.
Vascular dementia is the second most common form of dementia 
in the United States, and causes an estimated 50% of dementia cases 
in Japan. Binswanger’s disease is a cause of vascular dementia (World 
Health Organization, 1993), and is most commonly observed in the 
fifth and sixth decades of life. Slightly more common among men, 
Figure 3 | gradient echo.
Figure 4 | Hematoxylin and eosin staining.
Figure 5 | Hematoxylin and eosin staining.
Figure 6 | Luxol fast blue staining.
Figure 7 | gFAP stain.
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likely to have hypotensive events at pressures otherwise consid-
ered as normal (Sulkava and Erkinjuntti, 1987). These events 
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gregants (mainly aspirin) are used in the prevention of cardio-
vascular and cerebrovascular disease (Sterzer et al., 2001). In one 
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it is associated with arterial hypertension and diabetes mellitus. The 
disease starts with mild decrease in cognitive function, referred to as 
vascular cognitive impairment (Bowler and Hachinski, 1995, 2003). 
The cognitive decline is gradual in the beginning and worsens with 
new clinical events. As the disease progresses further decrease in the 
cognitive function may not be associated with new clinical events 
(Pohjasvaara et al., 2003). According to criteria defined by Bennett 
et al., Binswanger’s disease is diagnosed by the presence of dementia 
on clinical examination or neuropsychological testing and the pres-
ence of either vascular risk factors with cerebrovascular disease or 
subcortical dysfunction. There should be bilateral subcortical white 
matter involvement, without cortical involvement on cranial com-
puted tomography or magnetic resonance imaging (Bennett et al., 
1990).The dementia is characterized by a predominantly frontal dys-
executive syndrome with mild memory impairment. Dysarthria, gait 
impairment, and bladder incontinence may occur early in the disease 
process (Baezner et al., 2008). Some patients may have mania (Caplan 
and Schoene, 1978), depression (Pohjasvaara et al., 2003) or mood 
instability with clinical fluctuations (Delong et al., 1974).
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splitting of the internal elastic lamina, with some occluded vessels. 
The endothelium is often intact. Some vessels show hypertrophy 
of smooth muscle cells (Akiguchi et al., 1997).
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